We are live on
!
Find out more
ACM
Arlington Capital Management Portfolio holdings
AUM
$161M
1-Year Est. Return
38.38%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+38.38%
3 Year Est. Return
+153.55%
5 Year Est. Return
+294.8%
10 Year Est. Return
+509.37%
AUM
$140M
AUM Growth
+$21.5M
(+18%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
8.59%
Top 10 Holdings %
Top 10 Hldgs %
80.09%
Holding
39
New
8
Increased
16
Reduced
6
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$7.03M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$1.97M |
| 3 |
Cohen & Steers REIT and Preferred and Income Fund
RNP
|
+$1.43M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$1.4M |
| 5 |
FirstEnergy
FE
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$6.11M |
| 2 |
Lumen
LUMN
|
+$1.36M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.27M |
| 4 |
HPF
John Hancock Preferred Income Fund II
HPF
|
+$983K |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$811K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.41% |
| 2 | Healthcare | 10.9% |
| 3 | Industrials | 9.12% |
| 4 | Financials | 1.76% |
| 5 | Real Estate | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Biotechnology ETF
IBB
$9.45B
| $18.6M | 13.29% |
162,183
+12,675
| +8% | +$1.4M |
|
|
2
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
| $16.6M | 11.9% |
399,107
+190,472
| +91% | +$7.03M |
|
3
iShares US Healthcare Providers ETF
IHF
$1.22B
| $14.8M | 10.61% |
556,770
+46,575
| +9% | +$1.16M |
|
4
iShares S&P India Nifty 50 Index Fund
INDY
$558M
| $13.3M | 9.5% |
423,378
+36,186
| +9% | +$1.16M |
|
5
iShares US Transportation ETF
IYT
$2.28B
| $13.3M | 9.49% |
338,568
+29,100
| +9% | +$1.17M |
|
6
Bath & Body Works
BBWI
$3.97B
| $8.88M | 6.36% |
116,514
+10,402
| +10% | +$751K |
|
7
Southwest Airlines
LUV
$21.7B
| $8.66M | 6.2% |
195,581
+16,476
| +9% | +$720K |
|
8
Ulta Beauty
ULTA
$21.8B
| $8.45M | 6.05% |
55,986
+4,729
| +9% | +$655K |
|
|
9
BioMarin Pharmaceuticals
BMRN
$11.9B
| $5.61M | 4.02% |
44,989
+18,550
| +70% | +$1.97M |
|
|
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
| $3.72M | 2.67% |
57,690
+5,336
| +10% | +$306K |
|
11
XPO
XPO
$23.4B
| $3.39M | 2.42% |
215,285
+18,757
| +10% | +$272K |
|
12
Vertex Pharmaceuticals
VRTX
$123B
| $3.31M | 2.37% |
28,101
+2,557
| +10% | +$306K |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $3.29M | 2.36% |
28,569
+2,741
| +11% | +$328K |
|
14
Amgen
AMGN
$209B
| $3M | 2.15% |
18,789
+1,852
| +11% | +$292K |
|
|
AMJ
15
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.93M | 1.38% |
45,133
-1,336
| -3% | -$58.9K |
|
|
MPT
16
Medical Properties Trust
MPT
$2.84B
| $1.64M | 1.17% |
111,175
+4,423
| +4% | +$65.7K |
|
|
17
Cohen & Steers REIT and Preferred and Income Fund
RNP
$989M
| $1.43M | 1.02% |
+73,445
| New | +$1.43M |
|
18
Bank of America Series L
BAC.PRL
$3.93B
| $1.41M | 1.01% |
1,220
+403
| +49% | +$472K |
|
|
FLG
19
Flagstar Bank National Association
FLG
$5.87B
| $1.36M | 0.97% |
27,011
-655
| -2% | -$31.9K |
|
|
20
FirstEnergy
FE
$28.4B
| $1.31M | 0.94% |
+37,298
| New | +$1.4M |
|
21
iShares Mortgage Real Estate ETF
REM
$549M
| $1.27M | 0.91% |
27,152
-732
| -3% | -$34.4K |
|
|
HTS
22
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $1.25M | 0.9% |
68,859
-2,236
| -3% | -$40.7K |
|
23
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
| $779K | 0.56% |
+81,670
| New | +$733K |
|
24
Procter & Gamble
PG
$340B
| $510K | 0.37% |
+6,226
| New | +$535K |
|
25
Philip Morris
PM
$309B
| $429K | 0.31% |
5,695
-172
| -3% | -$14K |
|
Similar funds
FPWM
GWA
RCWM
IC
PCC
MWM
CF
CCW
Arlington Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Arlington Capital Management held 39 positions worth $140M, up 18% from $118M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Arlington Capital Management deployed $12M of net new capital in Q1 2015, opening 8 new positions and adding to 16 existing holdings. Its largest new stake was Cohen & Steers REIT and Preferred and Income Fund: 73,445 shares worth $1.43M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $58.9K trimmed.
- Arlington Capital Management's largest Q1 2015 buy was Cohen & Steers REIT and Preferred and Income Fund: 73,445 shares worth $1.43M.
- Arlington Capital Management added most to Xtrackers Harvest CSI 300 China A-Shares ETF in Q1 2015, an estimated $7.03M increase.
- Arlington Capital Management's biggest Q1 2015 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $58.9K.
- Arlington Capital Management fully exited iShares China Large-Cap ETF in Q1 2015, selling an estimated $6.11M.
- Arlington Capital Management's ten largest holdings make up 80% of its $140M portfolio in Q1 2015.
- Arlington Capital Management opened 8 new positions and closed 9 in Q1 2015.
- Arlington Capital Management's portfolio value rose 18% quarter-over-quarter to $140M.
Based on Arlington Capital Management's 13F filing for Q1 2015, filed 12 May 2015.